Does testosterone therapy actually fix low libido in menopause?

What did @drmaryclaire actually say?

The claim here is focused and specific, which is refreshing. She says the strongest evidence for testosterone in women is around sexual desire, that it's "documented best in women who have their ovaries removed," and that it's "documented but less well" in women who go through natural menopause. She also says it "works in both" groups for sexual desire. This is a clinically grounded take, not a broad hormone-hype pitch.

Notably, she's not claiming testosterone fixes fatigue, brain fog, weight gain, or mood. She's drawing a clear line around what the evidence actually supports. That kind of restraint is rare in this content category, and it deserves acknowledgment before we get into the details.

Does the science back this up?

Yes, with some important nuance. The strongest body of evidence for testosterone and female sexual dysfunction comes from randomized controlled trials in surgically menopausal women, where the hormonal drop is abrupt and severe. The landmark APHRODITE trial (Davis et al., 2008, New England Journal of Medicine) showed that a 300-microgram transdermal testosterone patch significantly improved satisfying sexual events and desire scores in naturally menopausal women, but that cohort included women already on estrogen therapy.

For surgically menopausal women, the data goes back further and is more consistent. Shifren et al. (2000, NEJM) showed meaningful improvements in sexual function and well-being with transdermal testosterone in women who had bilateral oophorectomy. The 2019 Global Consensus Statement on testosterone therapy for women (Wierman et al. and others, Journal of Clinical Endocrinology and Metabolism) concluded that testosterone has evidence for treating hypoactive sexual desire disorder in postmenopausal women, period. It does not endorse its use for other symptoms like bone density or cognitive function due to insufficient data.

What did they get wrong (or right)?

They got the hierarchy of evidence right. Surgical menopause does produce better-documented outcomes in trials, partly because the patient population is more uniform and the hormonal deficit is more dramatic. Natural menopause studies are messier because testosterone decline in that group is more gradual and variable.

Where the nuance gets lost is the phrase "it works in both." That's accurate in a broad sense, but the effect sizes differ, and many natural menopause trials co-administered estrogen, making it hard to isolate testosterone's contribution. The 2019 consensus statement was careful to note that most high-quality trials enrolled women already using systemic estrogen. Women not on estrogen therapy are underrepresented in the top-tier evidence. That distinction matters clinically, and it doesn't get surfaced here.

The creator also doesn't mention that no testosterone product is currently FDA-approved for women in the United States, which is a significant regulatory gap that any patient considering this treatment should know about.

What should you actually know?

If you're in perimenopause or postmenopause and experiencing low sexual desire that's bothering you, testosterone therapy is a legitimate clinical conversation to have. The evidence supports it specifically for hypoactive sexual desire disorder in postmenopausal women. It is not a catch-all hormone fix, and the science does not currently support using it for energy, cognition, or body composition in women, regardless of what you see elsewhere on this app.

The absence of FDA-approved formulations for women means that prescribing happens off-label, typically using male-formulated products at lower doses or compounded preparations. Compounded testosterone products are not FDA-approved and have not undergone the same manufacturing and efficacy review as approved drugs. That is not a reason to dismiss the therapy, but it is a reason to work with a clinician who monitors levels and adjusts carefully.

• Testosterone levels should be measured before initiating therapy and monitored during treatment.
• Side effects at supraphysiologic levels include acne, hair growth, and voice changes.
• Long-term safety data in women, particularly for cardiovascular and breast outcomes, remains limited.

Bottom line: is this worth trusting?

More than most TikTok hormone content, yes. The creator is making a defensible, evidence-grounded claim that aligns with the 2019 international consensus position. The limitation is what she doesn't say: the evidence base is stronger when estrogen is also present, no product is FDA-approved for women, and "works for sexual desire" should not be read as "works for everything you're experiencing in menopause." Take the core point, but fill in those gaps before making any treatment decisions.